(Press-News.org) DANVERS, Mass., February 20, 2025 – Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery Awareness Day today, February 20. Recognized through a U.S. Congressional resolution, this designation will help increase awareness of heart health and how innovative medical technology helps patients return home to their families – with their native heart. There are events taking place across the country where patients are sharing their stories, including heart recovery reunions and sessions to educate healthcare providers, which underscore the impact that heart recovery has on patient lives.
According to the World Health Organization, an estimated 17.9 million people died from cardiovascular diseases in 2019, representing 32% of all global deaths.[1] Heart Recovery Awareness Day demonstrates the potential for patients with complex heart disease and advanced heart failure to recover their native heart and improve their quality of life after a heart event.
“Years ago, heart recovery was just an idea. Today, because of innovations in cardiac care, many patients around the world can not only survive a major heart event but go on to live full, vibrant lives with their native hearts,” said Chuck Simonton, Chief Medical Officer, Heart Recovery, Johnson & Johnson MedTech.
Heart recovery is enabled by inserting Impella, the world’s smallest heart pump, to temporarily take over the heart’s pumping function, allowing the heart to rest and recover while maintaining the flow of oxygenated blood throughout the body. This therapy enables patients to return to their life and families with their native heart and experience an equal - or improved – quality of life.
The platform of Impella heart pumps has been used to treat more than 330,000 patients globally. In 2024, a randomized clinical trial published in the New England Journal of Medicine[2] confirms routine use of Impella CP in patients who have had a heart attack with STEMI cardiogenic shock reduces 180-day mortality by 12.7% compared to the control arm (45.8% vs. 58.5%, p=0.04). The authors also stated that the increased risk of adverse events does not overshadow the benefit of treatment with Impella CP.
Patient Benefits from Heart Recovery and CPR
Jim Hart[3] (pictured, left, with his family) is a father of three, a college professor and pastor from New Jersey who, at the age of 43, began experiencing severe chest pain and collapsed at his home. His two oldest sons began giving Jim cardiopulmonary resuscitation (CPR) compressions while his youngest son called 911. Once at the hospital, it was determined that Jim was in cardiogenic shock and his heart was failing. He was taken to the cardiac catheterization lab and an Impella CP heart pump was implanted to allow Jim’s heart to rest before physicians placed stents. After a few days of support, Jim’s heart function improved. The Impella CP heart pump was removed and Jim returned home with his recovered heart.
According to the American Heart Association, approximately 90% of people who experience a cardiac arrest outside of a hospital die. If CPR is performed immediately, these individuals have double or triple the chance of survival compared to those who do not receive CPR.[4]
“As we learned from Jim’s story of heart recovery, CPR plays a critical role in helping patients survive a cardiac arrest and we look forward to working with the American Heart Association to increase the availability of CPR training tools and resources in Boston and beyond,” added Simonton.
In recognition of the inaugural National Heart Recovery Awareness Day, Johnson & Johnson MedTech is collaborating with the American Heart Association to bring the first hands-only CPR teaching kiosk to Boston. The teaching tool will be in the “Hall of Human Life” at the Museum of Science, Boston, as part of its Being Human spotlight, a yearlong exploration of human connectivity and the ways we can all better the lives we live.
Located in more than 30 cities across the country, the hands-only CPR kiosks teach the two simple steps of hands-only CPR, which can be used in teens and adults who suddenly collapse from cardiac arrest and guides the user on how to effectively deliver CPR until help arrives.
Heart Recovery Awareness Day Across the U.S.
In honor of National Heart Recovery Awareness Day, there are more than 10 heart recovery reunions taking place in February, celebrating more than 50 patients across the country. At these events, Impella patients in Ohio, Texas, Florida, Louisiana and California – among other locations – will be reuniting with members of their care teams and sharing their personal stories of heart recovery. Additionally, many patients will be sharing their stories of heart recovery at community and educational events, including the annual Utah Cardiac Recovery Symposium.
About Cardiovascular Solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges. Through a cardiovascular portfolio that provides healthcare professionals with advanced mapping and navigation, miniaturized tech, and precise ablation we are addressing conditions with significant unmet needs such as heart failure, coronary artery disease, stroke, and atrial fibrillation. We are the global leaders in heart recovery, circular restoration and the treatment of heart rhythm disorders, as well as an emerging leader in neurovascular care, committed to taking on two of the leading causes of death worldwide in heart failure and stroke. For more, visit www.heartrecovery.com and follow us on LinkedIn and @jjmt_heartrecov.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. Abiomed, Inc. is part of Johnson & Johnson MedTech.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the Impella Platform. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Abiomed, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of regulatory approvals; uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of healthcare products and services; and trends toward healthcare cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s most recent Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at sec.gov, jnj.com or on request from Johnson & Johnson. Neither Abiomed, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.
[1] https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa2312572
[3] Jim Hart was not compensated for the inclusion of his story in this press release.
[4] https://cpr.heart.org/-/media/cpr-files/courses-and-kits/hands-only-cpr/handsonly-cpr-fact-sheet-ucm_502250.pdf?la=en&hash=3B377AD41A9262042382D3A3D14D1AB5DA1E51A1
END
Johnson & Johnson MedTech celebrates inaugural National Heart Recovery Awareness Day
Impella patients share stories of heart recovery at reunions, events across the country; Launch of Boston’s first Hands-Only CPR kiosk with American Heart Association
2025-02-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Novel inhalable gene therapy trialled for people with cystic fibrosis
2025-02-20
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Cystic fibrosis (CF) is caused by defects in the CFTR gene, which causes a buildup of thick sticky mucus in the lungs and digestive system. It causes lung infections and gradually affects the ability to breathe. The new lentiviral vector-based gene therapy works by inserting a functioning copy of the CFTR gene in the DNA of the epithelial cells in a patient’s airway.
At ...
Plasma arc cutting: PNU and KIMM scientists together decode gas flow dynamics
2025-02-20
Plasma arc cutting (PAC) is a thermal cutting technique widely used in manufacturing applications such as shipbuilding, aerospace, fabrication, nuclear plants decommissioning, construction industry, and the automotive industry. In this process, a jet of plasma or ionized gas is ejected at high speeds, which melts and subsequently removes unwanted parts of materials from electrically conductive workpieces such as metals. The plasma jet is typically produced in two steps: pressuring a gas through a small nozzle hole and generating an electric arc via power supply. Remarkably, the introduced arc ionizes ...
Exercise your way to lower blood pressure: Brain pathway to fight high blood pressure
2025-02-20
Hypertension (high blood pressure) is a debilitating condition and a major cause of premature death worldwide. Chronic stress plays a significant role, but the underlying mechanism involving biochemical pathways by which stress leads to hypertension has not been well understood. Understanding these pathways could lead to the development of therapeutic agents to combat hypertension. Now, a new study from Juntendo University, Japan, led by Professor Hidefumi Waki, Dr. Keisuke Tomita, and Dr. Ko Yamanaka, published online in the journal Acta Physiologica on January 13, 2025, has shown that voluntary ...
Scientists call for efforts to protect habitats of critically endangered shark species
2025-02-20
A critically endangered species of shark could be forced to adapt to new habitats – or face extinction – as a result of changes in the ocean predicted to occur as a result of climate change, a new study has suggested.
The whitefin swellshark (Cephaloscyllium albipinnum) is a species of catshark found in deeper waters just off Australia’s south and east coasts. Its precise population numbers are uncertain, but the species has been assessed by the International Union for Conservation of Nature (IUCN) as Critically ...
New ACS study shows cancer mortality rates among Black people declining, but remain higher than other racial and ethnic groups
2025-02-20
The American Cancer Society (ACS) today released Cancer Statistics for African American and Black People, 2025. According to the report, the cancer mortality rate declined from 1991 to 2022 by 49% and 33% in Black men and women, respectively, in the United States. However, African American and Black people continue to have a disproportionately elevated cancer burden compared to other population groups. According to the study, the risk of cancer death for Black individuals is two-fold that of White individuals for myeloma, prostate, uterine corpus (endometrial), and stomach cancers, and 40%-50% higher for colorectal, ...
Latest research finds people with certain heart conditions may play competitive sports
2025-02-20
Statement Highlights:
Although people with cardiovascular abnormalities have previously been considered ineligible for competitive sports participation, new evidence indicates that athletes of all ages who have certain heart abnormalities or diseases may often safely participate in competitive sports.
A new joint scientific statement from the American Heart Association and the American College of Cardiology emphasizes the need for shared decision-making between athletes and their clinicians, and provides guidance for health care professionals about how to assess risk when considering competitive sports participation for people with various cardiovascular conditions.
More ...
Biologists discover a new type of control over RNA splicing
2025-02-20
CAMBRIDGE, MA -- RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, portions of the RNA that don’t code for proteins, called introns, are cut out and the coding portions are spliced back together.
This process is controlled by a large protein-RNA complex called the spliceosome. MIT biologists have now discovered a new layer of regulation that helps to determine which sites on the messenger RNA molecule the spliceosome will target.
The research team discovered ...
Surprising finding for acid reducing drugs
2025-02-20
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the stomach, where they block acid production. Researchers at the German Cancer Research Center (DKFZ) made the surprising discovery that zinc-carrying proteins, which are found in all cells, can also activate PPIs – without the presence of gastric acid. The result could be a key to understanding the side effects of PPIs.
Excessive gastric acid can cause not only heartburn, but also chronic complaints such as gastritis or even a stomach ...
Pushing the limits of ‘custom-made’ microscopy
2025-02-20
A new paper updates an EMBL technology advance even further. More details about the original technology can be found in our initial reporting here.
EMBL tech developers have made an important leap forward with a novel methodology that adds an important microscopy capability to life scientists’ toolbox. The advance represents a 1,000-fold improvement in speed and throughput in Brillouin microscopy and provides a way to view light-sensitive organisms more efficiently.
“We were on a quest to speed up image acquisition,” said Carlo Bevilacqua, lead author on ...
Deep Nanometry reveals hidden nanoparticles
2025-02-20
Researchers including those from the University of Tokyo developed Deep Nanometry, an analytical technique combining advanced optical equipment with a noise removal algorithm based on unsupervised deep learning. Deep Nanometry can analyze nanoparticles in medical samples at high speed, making it possible to accurately detect even trace amounts of rare particles. This has proven its potential for detecting extracellular vesicles indicating early signs of colon cancer, and it is hoped that it can be applied to other medical and industrial fields.
Did you know your ...
LAST 30 PRESS RELEASES:
Precision therapy with microbubbles
LLM-based web application scanner recognizes tasks and workflows
Pattern of compounds in blood may indicate severity of gestational hypertension and preeclampsia
How does innovation policy respond to the challenges of a changing world?
What happens when a diet targets ultra-processed foods?
University of Vaasa, Finland, conducts research on utilizing buildings as energy sources
Stealth virus: Zika virus builds tunnels to covertly infect cells of the placenta
The rising tide of sand mining: a growing threat to marine life
Contemporary patterns of end-of-life care among Medicare beneficiaries with advanced cancer
Digital screen time and nearsightedness
Postoperative weight loss after anti-obesity medications and revision risk after joint replacement
New ACS research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
New frailty measurement tool could help identify vulnerable older adults in epic
Co-prescribed stimulants, opioids linked to higher opioid doses
What if we could revive waste carbon dioxide?
Mechanochemistry strikes again – A facile means for generating organolithium molecules
Breakthrough in high-performance oxide-ion conductors using rubidium
Hurricane-proofed downtown skyscrapers unexpectedly vulnerable to ‘bouncing’ winds
Microcomb chips help pave the way for thousand times more accurate GPS systems
Illuminating the proton’s inner workings
Genetic therapy gives infants life-changing improvements in sight
Impacts of workplace bullying on sleep can be “contagious” between partners
UK peatland fires are supercharging carbon emissions as climate change causes hotter, drier summers
Coastal erosion threatens this ancient city — and others much closer to home
Walgreens supports the American Heart Association to bring CPR to communities nationwide
How mosquitos hear may inspire new ways to detect natural disasters
Child ADHD risk linked to mother’s use of acetaminophen
New solution to help therapy ‘dropouts’
New AI system accurately maps urban green spaces, exposing environmental divides
Gordon Keller receives the 2025 ISSCR Achievement Award for his seminal work in regenerative medicine
[Press-News.org] Johnson & Johnson MedTech celebrates inaugural National Heart Recovery Awareness DayImpella patients share stories of heart recovery at reunions, events across the country; Launch of Boston’s first Hands-Only CPR kiosk with American Heart Association